ASTRAZENECA ELEVATES SOBI VELAUTHAPILLAI TO GLOBAL MARKETING DIRECTOR

AstraZeneca has promoted Sobi Velauthapillai to Global Marketing Director after nearly 19 years with the company. Previously EUCAN Regional Commercial Director based in Switzerland, she will now work from the United Kingdom. Her appointment underscores AstraZeneca’s focus on global marketing leadership and recognition of long-term internal talent.

AstraZeneca has announced the promotion of Sobi Velauthapillai to the role of Global Marketing Director, marking a significant milestone in her nearly two-decade-long career with the pharmaceutical giant. Velauthapillai, who has been with the company for close to 19 years, steps into the global leadership position after serving as EUCAN Regional Commercial Director.  

Her tenure at AstraZeneca has been defined by steady progression and a deep engagement with the company’s commercial and marketing strategies across diverse regions. In her previous role, Velauthapillai was based in Switzerland, where she oversaw commercial operations across Europe, Canada and other key markets. The move to the United Kingdom for her new assignment underscores AstraZeneca’s confidence in her ability to lead global marketing initiatives from one of its central hubs.  

Velauthapillai’s appointment reflects AstraZeneca’s continued focus on strengthening its global marketing leadership as the company navigates an increasingly complex pharmaceutical landscape. With her extensive experience and long-standing association with the organisation, she is expected to play a pivotal role in shaping AstraZeneca’s brand presence and market strategies worldwide.  

Her career trajectory highlights both loyalty and adaptability, qualities that have become increasingly valuable in the pharmaceutical sector, where long-term expertise and global perspective are critical to success. As Global Marketing Director, Velauthapillai will be tasked with driving AstraZeneca’s marketing vision across international markets, aligning regional strategies with global objectives, and ensuring the company remains competitive in a rapidly evolving industry.  

The promotion also signals AstraZeneca’s commitment to recognising and elevating internal talent, reinforcing the importance of continuity and institutional knowledge in leadership roles. Velauthapillai’s nearly 19 years with the company provide her with a unique understanding of its culture, values and long-term ambitions, positioning her to make a meaningful impact in her new role.